We speak to infectious diseases specialist, Ellie Goldstein (Santa Monica, CA, USA), about his recent publication on real world data and the challenges facing drug-resistant infections.
In line with our July focus around enteric infections, we recently spoke to Christina Faherty and Research Fellow from her lab, Alejandro Llanos-Chea, about the lab’s research on Shigella, Salmonella and E. coli and novel models for these in vitro.
Guy Thwaites, Director of the Oxford University Clinical Research Unit/Wellcome Program in Vietnam, speaks on neurotuberculosis and the challenges it faces in terms of treatment, HIV co-infection and the political will necessary for change.
In this interview, take a look behind the scenes of a recent Future Microbiology paper on the role of transition metal control in E. coli virulence with author, Jeffrey Henderson.
Take a look behind the scenes of a recent Future Virology article entitled ‘Latent vs productive infections: The alpha herpesvirus switch’ as we ask authors Lynn Enquist, Orkide Koyuncu and Margaret MacGibeny about latency, reactivation and the best models.
In this interview we take a look at cholera outbreak situations and the strategies required to tackle them as we talk to Martin Mengel following his presentation at ECCMID.
Take a look behind the scenes of a recent Future Virology review entitled ‘Antiviral therapeutic approaches for human rhinovirus infections’ as we ask author Peter Barlow about antivirals, antibodies and the host response.
Take a look behind the scenes of a recent Future Virology review as we ask author Geoffrey Dusheiko about the challenges facing hepatitis B and what the future may hold in terms of functional cure and new research directions.
In line with our focus this month on emerging technologies, we spoke to Eugene Koonin, Senior Investigator at the National Center for Biotechnology Information, about metagenomics and how it can be used to understand more about the global virome.
In our latest interview we ask Seth Berkley, who has been CEO of Gavi since 2011, about new vaccines, the importance of collaboration and the challenges facing access to vaccinations.